Dr. Madhu V. Midathada, MD
- Medicare services, 2024
- 213,968
- Medicare patients, 2024
- 895
- Part D claims, 2024
- 1,320
- Publications
- 2
- Clinical trials
- 1
- Practice address
- 4004 Pioneer Woods Dr, Lincoln, NE 68506
- Practice phone
- Call (402) 484-4900
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nebraska Hematology-Oncology
Lincoln, Nebraska
Find Dr. Midathada's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Madhu V. Midathada is a hematologist and oncologist in Lincoln, Nebraska
Dr. Midathada practices at Nebraska Hematology-Oncology in Lincoln, Nebraska.
Dr. Midathada's NPI, 1265511034, was assigned on November 3, 2006. Dr. Midathada holds Nebraska license 23290.
- NPI
- 1265511034NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7214971530
- NPI enumeration date
- November 3, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (402) 484-4900
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Madhu V. Midathada practices at Nebraska Hematology-Oncology in Lincoln, Nebraska
Dr. Midathada's primary practice is Nebraska Hematology-Oncology, at 4004 Pioneer Woods Dr, Lincoln, NE 68506 in Lancaster County. The practice phone is (402) 484-4900.
- Nebraska Hematology-Oncology4004 Pioneer Woods Dr, Lincoln, NE 68506 · Lancaster CountyPhone(402) 484-4900
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Madhu V. Midathada is affiliated with 9 sites of care and 3 medical groups
Dr. Midathada's primary practice is Nebraska Hematology-Oncology in Lincoln, Nebraska. Dr. Midathada is also affiliated with Bryan Medical Center. The medical group on file is Nebraska Hematology-Oncology. Dmand AI also links Dr. Midathada to 5 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Madhu V. Midathada's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Midathada practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nebraska Hematology-Oncology | Available with a free account |
| +8 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Madhu V. Midathada is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Midathada's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Midathada is licensed in Nebraska.
Specialties and state licenses
- Hematology and oncology, NebraskaPrimary
Hematologists and oncologists near Dr. Midathada
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Madhu V. Midathada billed Medicare for 213,968 services in 2024
CMS data shows 213,968 Medicare services from Dr. Midathada across 85 procedure codes in 2024, for 895 Medicare patients. Medicare paid $3,046,709 for them.
Dr. Midathada's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 153,4612024: 195,64627%
- Lab and pathology
- 2023: 5,3272024: 6,60024%
- Other services
- 2023: 5,2882024: 5,0934%
- Tests and treatments
- 2023: 2,9482024: 3,42516%
- Office and hospital visits
- 2023: 1,6332024: 1,7195%
- Surgery
- 2023: 1,3042024: 1,48514%
Where Dr. Midathada's Medicare services took place, 2024
- In an office213,953100%
- In a facility150%
Dr. Midathada compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Midathada
- Nebraska median
- Medicare services
- 213,968vs 1,322161.9 times
- Medicare patients
- 895vs 4082.2 times
- Part D claims
- 1,122vs 5492.0 times
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Midathada's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Midathada?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Midathada and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Madhu V. Midathada treated 895 Medicare patients in 2024, average age 75
CMS counts 895 Medicare patients who saw Dr. Midathada in 2024. The largest group is 65 to 74, with 416 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Midathada's median patient age at 69, with 65% women.
Dr. Midathada's Medicare patients by age, 2024
Dr. Midathada's Medicare patients by sex, 2024
- Women58966%
- Men30634%
Chronic conditions among Dr. Midathada's Medicare patients, 2024
- High blood pressure75%
- High cholesterol72%
- Cancer56%
- Arthritis47%
- Chronic kidney disease35%
- Diabetes29%
- Mood disorders28%
- Ischemic heart disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Midathada's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women65%
- Men35%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Madhu V. Midathada wrote 1,320 Medicare Part D claims in 2024
In 2024, Dr. Midathada wrote 1,320 Medicare Part D claims for 249 patients. 81% of them were for generic drugs. CMS names the drug for 1,122 of them, across 32 drugs with 11 or more claims each, at $2,406,698 in total drug cost. In 2023, CMS named 872 claims across 25 drugs.
Dr. Midathada's Part D claims by kind of drug, 2024
- Generic1,070 claims81%
- Brand-name250 claims19%
Dr. Midathada's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Midathada's Part D claims, 2024
- Opioids2%21 of 1,320 claims
- Antibiotics4%50 of 1,320 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8722024: 1,12229%
Drugs named by CMS: 32 in 2024, 25 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Madhu V. Midathada scored 82 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Midathada for performance year 2024. Dr. Midathada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Midathada's MIPS scores, performance year 2024
- 82of 100Final score
- 67.5of 100Quality
- 96of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Madhu V. Midathada has 2 publications on record
Dmand AI links 2 papers to Dr. Midathada in 2025. Dr. Midathada's most frequent co-authors are Eric J. Avery, MD, Mark R. Hutchins, MD and Joni A. Tilford, MD.
Dr. Midathada's most frequent co-authors
Recent publications by Dr. Midathada
See who Dr. Midathada researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Midathada works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Madhu V. Midathada has worked on 1 clinical trial
Dmand AI links Dr. Midathada to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Midathada that name 1 trial.
Conditions in Dr. Midathada's trials
- Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Midathada
- Nihal Essa Abdulla, MD1 shared trial
- Maysa M. Abu-Khalaf, MD1 shared trial
- Aisha Ahmed, MD1 shared trial
Recent clinical trials with Dr. Midathada
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Madhu V. Midathada received $32,713 in industry payments from 2016 to 2025
CMS Open Payments shows 109 general payments to Dr. Midathada from 40 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,879. It also lists 1 research payment totaling $462 in 2021, naming 1 clinical trial.
General payments to Dr. Midathada by program year, 2016 to 2025
General payments to Dr. Midathada by kind, 2016 to 2025
- Consulting fees$28,30487%
- Travel and lodging$2,6018%
- Food and beverage$1,5045%
- Education$3041%
Companies that paid Dr. Midathada the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Madhu V. Midathada's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Madhu V. Midathada
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Madhu V. Midathada's NPI number?
Dr. Madhu V. Midathada's NPI number is 1265511034. It was assigned on November 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Madhu V. Midathada?
Dr. Madhu V. Midathada is a hematologist and oncologist in Lincoln, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Madhu V. Midathada practice?
Dr. Midathada practices at 4004 Pioneer Woods Dr, Lincoln, NE 68506. Dr. Midathada's primary practice is Nebraska Hematology-Oncology in Lincoln, Nebraska. Dmand AI also links Dr. Midathada to 5 hospitals, 2 group practices and clinics and 2 medical groups.
What is Dr. Madhu V. Midathada's office phone number?
The practice phone on file for Dr. Midathada is (402) 484-4900.
What is Dr. Madhu V. Midathada's medical license number?
Dr. Midathada holds Nebraska license 23290.
Which hospitals is Dr. Madhu V. Midathada affiliated with?
Dr. Midathada is affiliated with Bryan Medical Center. Dmand AI links Dr. Midathada to 5 more hospitals.
What medical group is Dr. Madhu V. Midathada part of?
Dr. Midathada is linked to Nebraska Hematology-Oncology. Dmand AI links Dr. Midathada to 2 more medical groups.
Does Dr. Madhu V. Midathada accept Medicare?
Yes. CMS data shows Dr. Midathada billed Medicare for 213,968 services in 2024, and Dr. Midathada accepts Medicare assignment.
What is Dr. Madhu V. Midathada's MIPS score?
Dr. Midathada's MIPS final score for performance year 2024 is 82 out of 100.
How many Medicare patients does Dr. Madhu V. Midathada see?
CMS counts 895 Medicare patients who saw Dr. Midathada in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Madhu V. Midathada bill to Medicare?
In 2024, Dr. Midathada's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J9144) and injected or infused drug (J9271).
What drugs does Dr. Madhu V. Midathada prescribe most?
In 2024 Medicare Part D data, Dr. Midathada's most prescribed drugs by claims were Anastrozole, Letrozole and Tamoxifen Citrate.
Has Dr. Madhu V. Midathada received payments from drug or device companies?
CMS Open Payments shows $32,713 in general payments to Dr. Midathada from 40 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Madhu V. Midathada been practicing?
Dr. Midathada graduated from medical school in 1992, 34 years ago.
Does Dr. Madhu V. Midathada do research?
Dmand AI links 2 publications to Dr. Midathada. Dr. Midathada has worked on 1 clinical trial.
Who does Dr. Madhu V. Midathada publish with?
Dr. Midathada's most frequent co-authors are Eric J. Avery, MD (1 shared paper), Mark R. Hutchins, MD (1 shared paper) and Joni A. Tilford, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card